ABSTRACT-Adrenergic regulation of prostaglandin (PG) biosynthesis was investigated in 1-14C arachidonic acid-prelabeled cultured rabbit gastric epithelial cells (RGECs). RGECs expressed adrenergic a, and a-receptors and muscarinic receptors. Norepinephrine facilitated the synthesis of PGs 12 (determined as the stable metabolite 6-keto PGF,a) and E2 and hydroxyfatty acids, while epinephrine facilitated the syn thesis of PGI2 and hydroxyfatty acids, but not PGE2. However, isoproterenol did not affect PG biosyn thesis. The effects of norepinephrine and epinephrine on PG biosynthesis were markedly suppressed by the non-selective a-blocker phentolamine and/or the selective a,-blocker prazosin. In combination with epinephrine, the selective a2-blocker yohimbine or the p-blocker propranolol facilitated PGE2 synthesis. Acetylcholine did not affect PG biosynthesis. These results indicate that norepinephrine and epinephrine act on PG biosynthesis as adrenergic agonists in these cultured RGECs and that an a,-receptor couples PGI2 and PGE2 synthesis.
The mucosa and muscle layers of the stomach generate the major products of arachidonate metabolism, via a cyclooxygenase pathway (1 3), including prostaglandin (PG) E2 and PGI2i which are cytoprotective when ad ministered exogenously (4) , and thromboxane (TX) A2, which is ulcerogenic when administered exogenously (5) . It has been well documented that the decrease of PG biosynthesis in the stomach promotes ulcer formation, since cyclooxygenase inhibitors such as indomethacin and aspirin produce gastric ulcers (6, 7) . However, it has also been postulated that endogenous PGs are not necessary for either the induction or the healing of experimental acute gastric mucosal lesions (8) . Thus, despite the cytoprotective action of exogenously administered PGs, the significance of endogenous PGs in the protection of the gastric mucosa has not yet been defined (9) .
To elucidate the physiological role of endogenous PGs in the stomach, we attempted to determine what kinds of stimuli are the initiating factor(s) of PG synthesis. For this purpose, cultured rabbit gastric epithelial cells (RGECs) were used as a PG generating system. Cultured cells can produce considerable amounts of PGs without cofactors, such as reduced glutathione and catechol amines, which are usually used in in vitro experiments (1, 10) . Since reduced glutathione or catecholamines per se plays important roles in the physiological functions of the stomach (11, 12) , it is not desirable to use these agents as cofactors when we investigate the effects of drugs on PG biosynthesis in the gastric mucosa.
In this paper, we describe the effects of norepinephrine and epinephrine on PG biosynthesis in cultured RGECs and discuss their roles in gastric functions.
MATERIALS AND METHODS

Prostaglandin biosynthesis
Cultured RGECs (13) were prepared by the method of Matuoka et al. (14) . Briefly, the fetuses of JW/NIBS white rabbits were removed on day 24 of gestation. The stomachs were isolated, everted and then digested by 0.2% Pronase E (Kaken Chemicals, Tokyo). The dis persed epithelial cells were seeded in plastic dishes and subcultured in a split ratio of 2:1 in Dulbecco's Modified Eagle Medium (DMEM; Nissui Pharm, Tokyo) contain ing 20% fetal bovine serum (FBS; Gibco, Gaithersburg, MD, USA), 100 ig/ml Kanamycin (Meiji Seika, Tokyo), 100 units/ml of penicillin G potassium salt (Meiji Seika) and 50 units/ml of Dispase I (Godo Shusei, Tokyo) in a CO2 incubator (5016 CO2 in humid air set at 371C). At population doubling level6, the cells were frozen at 80'C and stocked. The frozen cells were used within 2 months. Before the experiments, the frozen cells were thawed and cultured. After confluence (population dou bling level 7), the cells were used following the experi ments.
The culture medium of the confluent cells in a dish (di ameter of 6 cm, Corning 25010; Corning, NY, USA) was changed to 10% FBS-DMEM containing 9,250 Bq of 1 14C -arachidonic acid (AA) (2 ,220 mBq/mol; New England Nuclear, Boston, MA, USA). After incubation in a CO2 incubator at 371C for 24 hr, the medium was discarded, and the cells were washed with 10%16 FBS-DMEM. Then 4 ml of 10% FBS-DMEM containing various drugs was ad ded to the dishes. After 1, 6 or 24 hr, the medium was re moved, and the cells were washed with 10016 FBS-DMEM. The washing fluid was pooled together with the medium. The remaining cells were dispersed with 3 ml of 1 N NaOH.
The medium was adjusted to pH 3 with 1 N HCl, and after the addition of 5 pg of each carrier (PGA2, PGB2, PGD2, TXB2, PGE2, PGFIa and 6-keto PGFIa; Ono Phar maceuticals, Osaka), the medium was extracted twice with 4 ml of ethylacetate. The ethylacetate layer was evaporated to dryness under reduced pressure. The residue was dissolved in 80 pl of ethylacetate and spotted on an activated (110 C overnight) silica gel TLC plate (Merck 5221; Merck, Darmstadt, Germany). After de velopment with an A9 solvent system (15) (organic phase of ethylacetate : 2,2,4-trimethyl pentane : acetic acid : water, 110:50:20:100), the Rfs of authentic standards were visualized by iodine vapors and recorded. Radioac tivities on the TLC plate were recorded by TLC radioscan ning and autoradiography (Fig. 1) . The zones of radioac tive materials (as determined by autoradiograms) on the TLC plate were scraped off, and the radioactivity was de termined by a liquid scintillation counter (Tri-Carb 4640; Packard, Meriden, CT, USA).
The drugs used in this experiment were: (-)-norepi nephrine hydrochloride (NE), (-)-epinephrine bitartrate (EP), phentolamine hydrochloride, yohimbine hydrochlo ride, (-)-isoproterenol hydrochloride, acetylcholine chlo ride and dl-propranolol hydrochloride (Sigma, St. Louis, MO, USA); Ca 21 ionophore A23187 (Calbiochem, La Jol la, CA, USA); and prazosin hydrochloride (Taito Pfizer, Tokyo).
The effect of NE on the uptake of 14C-AA by the cul tured cells was also investigated. In this experiment, the cells were incubated with 10°10 FBS-DMEM containing 9, 250 Bq of 14C-AA and NE. Four hours later, the radioac tivities of the medium and cells were determined. The radioactive metabolites of 14C-AA in the medium were de termined as described above.
Receptor binding assays for al and a-receptors and mus carinic receptors The cells at population doubling level 7 were tryp sinized as described above. Receptor binding assays were performed with radiolabeled ligands: 3H-prazosin (2,516 mBq/mol; Amersham, Little Chalton, UK), 3H-dihydro alprenolol hydrochloride (DHA, 1,402 mBq/mol, New England Nuclear) and 3H-quinuclidinyl benzilate (QNB, 455 mBq/mol, Amersham) and non-labeled displacers:
phentolamine mesilate (Ciba-Geigy (Japan), Takarazuka), dl-propranolol hydrochloride (Sigma) and atropine sulfate (Nacalai Tesque, Kyoto). Various 3H-radiolabeled ligands were added to 1 ml of the cell suspension (106 cells/ml) and incubated at 251C for 30 min except for 3H QNB binding (60 min). For the termination of the bind ing reaction, the cell suspension was diluted with 3 ml of ice cold Tris-HCl buffer (pH 7.4) and filtered rapidly un der vacuum through Whatmann glass fiber filters (GF/B). The filters were washed 3 times with the buffer, and the radioactivity retained was determined with a liquid scintil lation counter. Non-specific binding was estimated with parallel assay tubes containing 10-5 M phentolamine for 3H -prazosin binding , propranolol for 3H-DHA binding and atropine for 3H-QNB binding.
Statistical analyses
The significance of difference of the means was verified by the Dunnett method (16), except when only two means were compared. In the latter case, the Student or Welch Aspin (for significantly different variations between two groups) t-test was employed.
RESULTS
PG biosynthesis
The A9 solvent system was reported to be useful for separation of 6-keto PGFIa from TXB2 and PGE2, but not for separation of TXB2 and PGE2 (15) . However,
[3H]-6-keto PGFIa, [3H]-TXB2 and [14C]-PGE2 added to and extracted from the culture medium were separated by using an A9 solvent system (Fig. 1) .
Radioactive materials extracted from the medium were 6-keto PGFIa, PGE2, hydroxyfatty acids (HFAs, several bands near AA), AA, polar compounds (substances present originally on the TLC plate, including phospho lipids and probably peptidoleukotrienes) and other minor metabolites, but TXB2 was absent (Fig. 2, Medium A) . The radioactivity released into the medium during a 24-hr incubation was 9-30% of the total radioactivity. Radioactive materials extracted from the cells were phos pholipids and an unknown substance(s) with less polarity than AA and its methyl ester. No PG was detected in the cellular extract: i.e., PGs generated were completely re leased into the medium (Fig. 2, Cell) . However, the less polar unknown substance(s) was released into the medi um by 2 x 10-6 M calcium ionophore A23187 (Fig. 2,  Medium B) . The release of radioactive materials into the medium was increased by 10-8-10-6 M NE but not by 10-'M acetylcholine ( 10-6 M NE significantly facilitated the release of AA into the medium and the biosynthesis of PGI2 in comparison with the controls, but did not significantly change PGEZ. In a 6 or 24-hr incubation, NE greatly facilitated 6-keto PGFIa and PGE2 biosynthesis and reduced free AA in comparison with that in a 1-hr incubation (Fig. 3) . EP (10-6 M) significantly facilitated the biosynthesis of 6 keto PGFIa and reduced AA but did not affect PGE2 syn thesis in comparison with the controls after a 24-hr incu bation (Fig. 4) . Isoproterenol (10-6 M) had no effect on PG synthesis (data not shown). A p-blocker, propranolol (10-6 M), in combination with 10-'M EP enhanced the synthesis of PGE2 (Fig. 4) , while it did not alter the effect of 10-6 M NE significantly (Fig. 5) . A nonselective a blocker, phentolamine (10-6 M), suppressed the release of radioactive materials into the medium and the PG syn thesis facilitated by 10-6 M EP and 10-6 M NE (Figs. 4  and 5 ). An a2-blocker, yohimbine (10-6 M), in combina tion with 10-6 M EP, greatly enhanced PGE2 synthesis (Fig. 4) , but did not change the effect of 10-6 M NE (Fig.  5) . Propranolol, phentolamine or yohimbine alone had no effect on PG biosynthesis. A selective a,-blocker, prazosin (10-6 M), almost completely inhibited the re lease of radioactive materials into the medium and the biosynthesis of 6-keto PGFIa, PGE2 and HFAs induced by NE, although it alone showed no effect on PG synthe sis (Fig. 6) . During a 4-hr incubation of RGECs with 9,250 Bq (4.17 nmol) of 1-14C-AA, the cells took up 71.7010 (ca. 3 nmol AA) of the radioactivity. The uptake of radioactiv ity was not modified by 10-6 M NE (70.2%). During a 4 hr incubation, 10-6 M NE converted almost all free AA to 6-keto PGFIa, PGE2 and TXB2 and to a lesser extent to HFAs (Fig. 7) .
Radioreceptor assays Specific bindings of the ligands of a,-receptors (3H prazosin), of a-receptors (3H-DHA), and of muscarinic receptors (3H-QNB), were detected with saturable aspects (Fig. 8) . These findings confirmed the existence of ad renergic a, and (3-receptors and muscarinic receptors in RGECs. Significantly different from norepinephrine, t P < 0 .05. 
DISCUSSION
The cultured RGECs produced several PGs and HFAs from prelabeled AA, and all of these metabolites were re leased into the medium. TX was not generated from pre labeled AA in the RGECs. A non-polar unknown sub stance(s) was the only metabolite(s) of radiolabeled AA detected in the cell extracts. The chemical and physiol ogical properties of this unknown substance(s) were not determined in this study, but its identification and charac terization will be the focus of the next experiment. Adrenergic a, and n-receptors and muscarinic recep NE enhanced the biosynthesis of PGI2 (determined as the stable metabolite 6-keto PGF,a), PGE2 and HFAs, while EP enhanced the synthesis of PGI2 and HFAs, but not that of PGE2. Isoproterenol had no effect on PG syn thesis. The effectiveness of NE and EP and the ineffective ness of isoproterenol on PG biosynthesis are consistent with their effects on PGI2 release in the rat aorta (17) and the human urinary excretion of PGs (18) . These differ ences of isoproterenol and native catecholamines may be due to the abilities to stimulate adrenergic receptors (19) ; isoproterenol stimulates only (3-receptors even at 10-5 M, while EP stimulates both (3 and a-receptors. Therefore, p-receptors may not affect PG biosynthesis.
None of the effect of NE on PG biosynthesis was affect ed by the (3-blocker propranolol, suggesting that the facilitatory effect of NE on PG synthesis was not mediat ed via (3-receptors. Enhancement of PGI2 synthesis in duced by NE and EP was inhibited by the non-selective adrenergic a-blocker phentolamine and/or the selective al-blocker prazosin. Therefore, it appears that PGI2 syn thesis may be mediated via adrenergic a,-receptors.
Synthesis of PGE2 was stimulated by NE and not affect ed by EP, which has more potent ~ action than NE. NE facilitated PGE2 production was inhibited by phentol amine and prazosin. These results suggest stimulatory mediation via adrenergic a,-receptors on PGE2 synthesis. In addition, PGE2 synthesis was enhanced by the combi nation of EP and the p-blocker propranolol or the a2 blocker yohimbine. These results suggest that adrenergic a2-receptors are involved in suppressing PGE2 synthesis stimulated by a,-receptors. However, the involvement of 13-receptors in suppressing PGE2 synthesis is uncertain since the p-agonist isoproterenol did not affect PG synthe sis.
These results in 14C-AA prelabeled cells indicate that catecholamines act on PG biosynthesis as adrenergic agonists. However, NE showed a different aspect in the distribution of PGs generated from exogenous 14C-AA in comparison with its effects in 14C-AA-prelabeled cells. In addition, NE facilitated conversion of exogenous 14C-AA to TXB2, which was not generated from prelabeled AA. Therefore, NE may act on PG biosynthesis from ex ogenous 14C-AA as a cofactor as shown in microsomes (1, 10) in addition to its role as an adrenergic agonist.
It is interesting that the stimulation of adrenergic a, receptors, which causes vasoconstriction, enhanced the synthesis of vasodilating (20) PGI2. This result suggests that catecholamines operate on the local regulatory func tions in the microcirculation by affecting PG biosynthesis in the gastric mucosa in addition to their direct actions on vascular smooth muscle. This production of PGI2 with ac tions on the vascular smooth muscles opposite to NE ac tion is consistent with the facilitation of PGI2 synthesis and the inhibition of TXA2 synthesis induced by vasocon stricting angiotensin in human umbilical arteries (21) .
It is known that PGI2 and PGE2 given exogenously are cytoprotective (4). However, it should be noted that PGI2 and PGE2 may promote bleeding from the damaged gas tric mucosa by inhibiting platelet aggregation (22) and vasodilatation. Therefore, it is considered that stimula tion of adrenergic a,-receptors may aggravate the develop ment of gastric mucosal lesions through its effects on gas tric PG biosynthesis.
It has been reported that cholinergic stimulation en hances PG biosynthesis in the isolated rat stomach (23) but not in the human stomach (24) . In the present study, acetylcholine did not stimulate PG biosynthesis in RGECs. These results suggest that the cholinergic system may be less important than the adrenergic system at least in the PG biosynthesis of this RGECs.
Production of PGI2 and PGE2 in sympathetic post ganglionic neurons has been shown to be mediated by adrenergic a2-receptors but not a,-receptors (25) . These facts and the results in the present study indicate the presence of different mechanisms regulating PG biosyn thesis in different cells and tissues and suggest that the roles of PGs may be different in various cells and tissues. Finally, it is concluded that catecholamines may regu late gastric functions by acting on epithelial PG biosynthe sis in addition to their direct vascular actions.
